Table 2 Comparison of clinical characteristics between the OP group and LCR group
OP (n = 22) (%) | LCR (n = 65) (%) | P-value | |
|---|---|---|---|
Sex | 0.805 | ||
Male | 8 (36.4) | 26 (40.0) | |
Female | 14 (63.6) | 39 (60.0) | |
Age, y (range) | 92 (90–98) | 92 (90–98) | 0.418 |
Body mass index, kg/m2 | 19.7 (12.9–28.8) | 20.3 (14.1 − 30.0) | 0.281 |
ASA performance status | 0.269 | ||
1 | 3 (13.6) | 6 (9.2) | |
2 | 13 (59.1) | 37 (56.9) | |
3 | 5 (22.7) | 22 (33.8) | |
4 | 1 (4.5) | ||
Comorbidities | 1.000 | ||
No | 3 (13.6) | 6 (9.2) | |
Yes | 19 (86.4) | 59 (90.8) | |
Tumor location | 1.000 | ||
Colon | 17 (77.3) | 49 (75.4) | |
Rectum | 5 (22.7) | 16 (24.6) | |
Operative procedure | 0.326 | ||
Ileocecal resection | 7 (31.8) | 13 (20.0) | |
Hemicolectomy | 5 (22.7) | 16 (24.6) | |
Partial resection | 4 (18.2) | 5 (7.7) | |
Sigmoidectomy | 0 (0) | 9 (13.8) | |
Anterior resection | 1 (4.5) | 8 (12.3) | |
Hartmann | 3 (13.6) | 7 (10.8) | |
Abdominoperineal resection | 2 (9.1) | 7 (10.8) | |
Clinical T factor | 0.021 | ||
1 | 0 (0) | 7 (10.8) | |
2 | 2 (9.1) | 10 (15.4) | |
3 | 9 (40.9) | 36 (55.4) | |
4 | 11 (50.0) | 12 (18.5) | |
Clinical N factor | 0.969 | ||
0 | 11 (50.0) | 36 (55.4) | |
1 | 7 (31.8) | 20 (30.8) | |
2 | 3 (13.6) | 9 (13.8) | |
Distant metastasis | 0.834 | ||
No | 20 (90.9) | 60 (92.3) | |
Yes | 2 (9.1) | 5 (7.7) | |
Operation time, min (range) | 146 (60–284) | 203 (77–560) | 0.002 |
Blood loss, mL (range) | 105 (5–843) | 20 (0–641) | 0.001 |
Blood transfusion, yes | 7 (31.8) | 9 (13.8) | 0.107 |
Open conversion | - | 1 (1.5) | |
Postoperative complications, CD ≥2 | 11 (50.0) | 24 (36.9) | 0.320 |
Duration of urethral catheter removal, days (range) | 4 (3–7) | 3 (2–7) | 0.052 |
Hospital stay, days (range) | 22 (11–59) | 18 (7–107) | 0.007 |
Re-admission within 30-days, yes | 2 (9.1) | 2 (3.1) | 0.264 |